Breast Cancer Awareness

Hope in Bloom During Breast Cancer Awareness Month

When you feel confident throughout your treatment journey – hope has every chance to bloom. At Onco360, we support our breast cancer patients every step of the way with expert clinical care, personalized guidance, and financial assistance solutions for eligible patients.

 

Cultivating Hope

Breast Cancer Awareness Month
Commitment to quality and service with a best-in-class patient satisfaction score (NPS) of 98*
 
Breast Cancer Awareness Month
94% of our breast cancer patients are very satisfied/satisfied with the support they received at Onco360**
 
Breast Cancer Awareness Month
98% of our breast cancer patients paid less than $25 out of pocket for their last dispense
 
Breast Cancer Awareness Month
Clinical programs developed by Board-Certified Oncology Pharmacists
 
 
 
 

Onco360 Dispenses These Breast Cancer Medications***

Afinitor® (everolimus)
Enhertu® (fam-trastuzumab)
Etcamah® (camizestrant)
Herceptin® (trastuzumab)
Ibrance® (palbociclib)
Inluriyo® (imlunestrant)
Itovebi™ (inavolisib)
Kadcyla® (ado-trastuzumab)
Keytruda® (pembrolizumab)
Kisqali® (ribociclib)
Nerlynx® (neratinib)

Orserdu® (elacestrant)
Perjeta® (pertuzumab)
Talzenna® (talazoparib)
Tecentriq® (atezolizumab)
Truqap® (capivasertib)
Tukysa® (tucatinib)
Tykerb® (lapatinib)
Veppanu™ (vepdegestrant)
Verzenio® (abemaciclib)
Xeloda® (capecitabine)

Bold = Limited Distribution Medication
***This list is a small portion of the comprehensive medications Onco360 can provide.

A Partnership Rooted in Hope

 
In honor of Breast Cancer Awareness Month, we’re partnering with the National Breast Cancer Foundation (NBCF) to bring a little extra comfort and encouragement to patients facing breast cancer. Through their thoughtful HOPE Kits, patients receive meaningful items created to remind them that they are seen, supported, and never alone. As part of our mission to improve the lives of patients battling cancer, we’re proud to sponsor 300 HOPE Kits for these patients throughout the month of October.
NBCF’s National Mammography Program
 

If you are a provider and would like to refer to Onco360, click below


HOW TO REFER

 

*Third-party survey data provided by MMIT. Report date Q3 2025. MMITnetwork.com
**Onco360 patient survey data collected Q2 2026